Z164597606
Z164597606 is a selective BChE inhibitor (IC50: 1.3 and 1.7 μM for eqBChE and hBChE). Z164597606 forms a π-π stacking interaction with the amino acid Trp82 of hBChE. Z164597606 can be used for the research of Alzheimer’s disease (AD).
For research use only. We do not sell to patients.
- CAS No.: 1050587-57-9
- Formula: C20H19N3O4
- Molecular Weight:365.38
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
eqBCHE 1.3 μM (IC50) |
hBCHE 1.7 μM (IC50) |
Z164597606 (10 μM) potently inhibits BChE activity, with no more than 30% inhibitory against ACHE[1].
Z164597606 (0.5-20 μM) may bind to catalytic “anionic” site (CAS) when interacting with BChE (determined by Lineweaver-Burk reciprocal plots)[1].
Z164597606 (10 and 50 μM) shows no toxicity on neuronal cell line SH-SY5Y[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1050587-57-9
-
Molecular Weight 365.38
-
Formula C20H19N3O4
-
SMILES
O=C(NC1=CC=CC=C1)CN(CC2=CC=CC=C2[N+]([O-])=O)CC3=CC=CO3
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Xin Lu, et al. Expansion of the scaffold diversity for the development of highly selective butyrylcholinesterase (BChE) inhibitors: Discovery of new hits through the pharmacophore model generation, virtual screening and molecular dynamics simulation. Bioorg Chem. 2019 Apr;85:117-127. [Content Brief]
[2]. Xin Lu, et al. Design, synthesis, and biological evaluation of aromatic tertiary amine derivatives as selective butyrylcholinesterase inhibitors for the treatment of Alzheimer's disease. Eur J Med Chem. 2022 Sep 2;243:114729. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)